Author  
Place of duty  
Title   ÁøÇ༺ À§¾Ï¿¡ ´ëÇÑ 5 - Fluorouracil ( 5 - FU ) 5 ÀÏ Áö¼ÓÁÖÀÔ ¹× Cisplatin º¹ÇÕÈ­Çпä¹ý : 5 - FU Ç÷Áõ³óµµ ÃøÁ¤ÀÇ ÀÇÀÇ ( Chemotherapy with Five - Day Continuous Infusion of 5 - Fluorouracil ( 5 - FU ) Plus Cisplatin for Advanced Gastric Cancer : Significance of 5 - FU Concentration Mon
Publicationinfo   2000 Jan; 032(03): 516-524.
Key_word   Stomach neoplasm , Continuous infusion , 5 - FU , Pharmacokinetics
Full-Text  
Abstract   Purpose: To investigate the therapeutic effects and toxicities of 5-day continuous infusion of 5-FU plus cisplatin FP chemotherapy in advanced gastric adenocarcinoma and to elucidate the relationship between the pharmacokinetic (PK) parameters and therapeutic outcome. Materials and Methods: Patients with previously untreated advanced stomach cancer were treated with FP chemotherapy. Plasma concentrations of 5-FU were measured using gas chromatography method for 5 days. Correlation of PK parameters of 5-FU with clinical outcome after FP chemotherapy was studied. Results: Response rate of FP chemotherapy was 46% (95% C.I.: 30-62%). There was a wide range of difference in the concentration and area under the curve (AUC) of 5-FU from patient to patient. We could find significant differences in AUC of 5-FU between the responders and the non-responders (p<0.05). Conclusion: We could confirm that FP chemotherapy was effective and tolerable for the treatment of advanced stomach cancer. The monitoring of plasma 5-FU concentration after chemotherapy and the adjustment of subsequent 5-FU dose seems to be necessary to improve the treatment outcome of FP chemotherapy.
Àú ÀÚ   ¹Ú¿¬Èñ(Yeon Hee Park),±èºÀ¼®(Bong Seog Kim),·ù¹é·Ä(Baek Yeol Ryoo),±èÅÂÀ¯(Tae You Kim),ÀÓ¿µÇõ(Young Hyuck Im),½ÅÈ£»ó(Ho Sang Shin),°­À±±¸(Yoon Koo Kang)